Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.

FBLG

FibroBiologics (FBLG)

FibroBiologics Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:FBLG
DataHoraFonteTítuloCódigoCompanhia
24/09/202417:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:FBLGFibroBiologics Inc
19/09/202410:31GlobeNewswire Inc.FibroBiologics Engages Southern Star Research as CRO in AustraliaNASDAQ:FBLGFibroBiologics Inc
12/09/202410:31GlobeNewswire Inc.FibroBiologics Announces Filing of Patent Application for Generation of Three-dimensional Organoids using Fibroblast Cell-Based TechnologyNASDAQ:FBLGFibroBiologics Inc
06/09/202410:31GlobeNewswire Inc.FibroBiologics to Present at the H.C. Wainwright 26th Annual Global Investment ConferenceNASDAQ:FBLGFibroBiologics Inc
27/08/202420:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:FBLGFibroBiologics Inc
20/08/202410:31GlobeNewswire Inc.FibroBiologics Announces Filing of Patent Application for Wound Healing Using an Adhesive Bandage with Fibroblast Cell-Based TechnologyNASDAQ:FBLGFibroBiologics Inc
15/08/202401:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:FBLGFibroBiologics Inc
13/08/202417:05Edgar (US Regulatory)Form POS AM - Post-Effective amendments for registration statementNASDAQ:FBLGFibroBiologics Inc
13/08/202417:01Edgar (US Regulatory)Form 3/A - Initial statement of beneficial ownership of securities: [Amend]NASDAQ:FBLGFibroBiologics Inc
07/08/202419:52GlobeNewswire Inc.FibroBiologics Files 2024 Second Quarter ReportNASDAQ:FBLGFibroBiologics Inc
07/08/202418:21Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:FBLGFibroBiologics Inc
15/07/202410:31GlobeNewswire Inc.FibroBiologics to Present at JonesTrading Healthcare Summit 2024NASDAQ:FBLGFibroBiologics Inc
25/06/202410:31GlobeNewswire Inc.FibroBiologics Announces Preliminary Proof of Concept for Novel Artificial Thymus Organoid TechnologyNASDAQ:FBLGFibroBiologics Inc
18/06/202417:12Edgar (US Regulatory)Form S-1 - General form for registration of securities under the Securities Act of 1933NASDAQ:FBLGFibroBiologics Inc
13/06/202410:31GlobeNewswire Inc.FibroBiologics Set to Join Russell 2000® IndexNASDAQ:FBLGFibroBiologics Inc
06/06/202411:58Edgar (US Regulatory)Form RW - Registration Withdrawal RequestNASDAQ:FBLGFibroBiologics Inc
06/06/202410:31GlobeNewswire Inc.FibroBiologics to Present at Extracellular Matrix Pharmacology Congress 2024NASDAQ:FBLGFibroBiologics Inc
04/06/202415:36Edgar (US Regulatory)Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]NASDAQ:FBLGFibroBiologics Inc
15/05/202417:30GlobeNewswire Inc.FibroBiologics Announces 2024 Annual Meeting of StockholdersNASDAQ:FBLGFibroBiologics Inc
15/05/202417:02Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:FBLGFibroBiologics Inc
14/05/202418:24GlobeNewswire Inc.FibroBiologics Files 2024 First Quarter ReportNASDAQ:FBLGFibroBiologics Inc
07/05/202410:31GlobeNewswire Inc.FibroBiologics to Present at the BIO International Convention 2024NASDAQ:FBLGFibroBiologics Inc
25/04/202409:00GlobeNewswire Inc.FibroBiologics Plans to Collaborate with Charles River to Manufacture Fibroblast-based SpheroidsNASDAQ:FBLGFibroBiologics Inc
11/04/202410:31GlobeNewswire Inc.FibroBiologics Granted Patent for Regeneration of Cartilage-Type Cells by the Australian Patent OfficeNASDAQ:FBLGFibroBiologics Inc
04/04/202410:31GlobeNewswire Inc.FibroBiologics Presents Data from Dermal Fibroblast Spheroid-based Treatment of Chronic Wounds in a Diabetes Mouse Model at Advanced Wound Care Summit USANASDAQ:FBLGFibroBiologics Inc
28/03/202410:31GlobeNewswire Inc.FibroBiologics Files Patent Application Covering Fibroblast-based Technology for the Potential Treatment of LupusNASDAQ:FBLGFibroBiologics Inc
19/03/202410:31PR Newswire (US)FibroBiologics Announces Preliminary Proof of Concept for Fibroblast-based Diabetes TreatmentNASDAQ:FBLGFibroBiologics Inc
13/03/202410:31PR Newswire (US)FibroBiologics to Present at Advanced Wound Care Summit USANASDAQ:FBLGFibroBiologics Inc
06/03/202411:31PR Newswire (US)FibroBiologics Appoints Ruben A. Garcia as General CounselNASDAQ:FBLGFibroBiologics Inc
29/02/202419:44PR Newswire (US)FibroBiologics Files 2023 Form 10-K Annual ReportNASDAQ:FBLGFibroBiologics Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:FBLG